The Innovation Firm

IAM Magazine Recognizes Hamilton Brook Smith Reynolds as a Recommended Patent Law Firm
July 17, 2013 - IAM Patent 1000
The following is an excerpt from this article in IAM Patent 1000. “Thriving boutique” Hamilton Brook Smith Reynolds has become a firm favourite on the Massachusetts...
More »
 
Principal Mary Murray Receives Outstanding Alumni Service Award from Suffolk University Law School
July 9, 2013
Hamilton Brook Smith Reynolds Principal Mary K. Murray, Ph.D. is to be this year’s recipient of the Outstanding Alumni Service Award from her alma mater Suffolk University Law...
More »
 
The Impact of the AIA
The Impact of the AIA Tap into our wealth of resources on the AIA.  Replay our recent webcasts on the AIA.  Or read the many informative alerts on several AIA ...
More »
 
Supreme Court Rules on Patentability of Genes in Myriad
June 19, 2013 - Hamilton Brook Smith Reynolds Alert
By: N. Scott Pierce
Isolated genes are not eligible for patent protection. cDNA is patent eligible under § 101. Patent eligibility requires an "act of invention." United States Patent...
More »
 
WEBCAST RECORDING: Trademark Basics - How to Select Good Trademarks and Effectively Protect Them
June 19, 2013
For many companies, their trademarks or brands are how the companies are held out to their customers and how they are perceived in the market place.  The trademark tells their...
More »
 
Fighting It Out in the Patent Office - Early Experiences and Observations about IPRs
June 19, 2013
On June 19, 2013, Susan Glovsky, Principal, co-presented the Boston Patent Law Association's Contested Matters Committee "Fighting It Out in the Patent Office - Early...
More »
 
Third-Party Clinical Trials Not Considered “Public Use”
June 18, 2013 - Hamilton Brook Smith Reynolds Alert
By: Kristen K. Salvaggio
Public use inquiry is focused on the knowledge obtained by the public during clinical trial of a drug, rather than on the extent of use of the drug. Confidentiality controls implemented...
More »
 
Bowman v. Monsanto Co. Raises Concerns for Buyers of Patented Self-Replicating Products
June 13, 2013 - Hamilton Brook Smith Reynolds Alert
Contributing Writer Chace Craig from Hamilton Brook Smith Reynolds The doctrine of patent exhaustion does not protect replication of genetically modified soybean seeds for...
More »
 

« previous | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | next »

IAM Magazine Recognizes Hamilton Brook Smith Reynolds as a Recommended Patent Law Firm
July 17, 2013 - IAM Patent 1000
The following is an excerpt from this article in IAM Patent 1000. “Thriving boutique” Hamilton Brook Smith Reynolds has become a firm favourite on the Massachusetts...
More »
 
Principal Mary Murray Receives Outstanding Alumni Service Award from Suffolk University Law School
July 9, 2013
Hamilton Brook Smith Reynolds Principal Mary K. Murray, Ph.D. is to be this year’s recipient of the Outstanding Alumni Service Award from her alma mater Suffolk University Law...
More »
 
The Impact of the AIA
The Impact of the AIA Tap into our wealth of resources on the AIA.  Replay our recent webcasts on the AIA.  Or read the many informative alerts on several AIA ...
More »
 
Supreme Court Rules on Patentability of Genes in Myriad
June 19, 2013 - Hamilton Brook Smith Reynolds Alert
By: N. Scott Pierce
Isolated genes are not eligible for patent protection. cDNA is patent eligible under § 101. Patent eligibility requires an "act of invention." United States Patent...
More »
 
WEBCAST RECORDING: Trademark Basics - How to Select Good Trademarks and Effectively Protect Them
June 19, 2013
For many companies, their trademarks or brands are how the companies are held out to their customers and how they are perceived in the market place.  The trademark tells their...
More »
 
Fighting It Out in the Patent Office - Early Experiences and Observations about IPRs
June 19, 2013
On June 19, 2013, Susan Glovsky, Principal, co-presented the Boston Patent Law Association's Contested Matters Committee "Fighting It Out in the Patent Office - Early...
More »
 
Third-Party Clinical Trials Not Considered “Public Use”
June 18, 2013 - Hamilton Brook Smith Reynolds Alert
By: Kristen K. Salvaggio
Public use inquiry is focused on the knowledge obtained by the public during clinical trial of a drug, rather than on the extent of use of the drug. Confidentiality controls implemented...
More »
 
Bowman v. Monsanto Co. Raises Concerns for Buyers of Patented Self-Replicating Products
June 13, 2013 - Hamilton Brook Smith Reynolds Alert
Contributing Writer Chace Craig from Hamilton Brook Smith Reynolds The doctrine of patent exhaustion does not protect replication of genetically modified soybean seeds for...
More »
 

« previous | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | next »

Back to the Top